JAZZ Earnings Jazz Pharmaceuticals Plc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | 7.17 | 2026-08-03 | 10-Q |
| Q1 2026 | 2026-03-31 | 4.43 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -5.84 | 2026-02-24 | 10-K |
| Q3 2025 | 2025-09-30 | -9.18 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | -13.28 | 2026-08-03 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.52 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | 8.65 | 2026-02-24 | 10-K |
| Q3 2025 | 2024-09-30 | 5.63 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | 2.35 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.23 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-31 | 6.10 | 2026-02-24 | 10-K |
| Q3 2024 | 2023-09-30 | 4.67 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | 2.55 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | 1.04 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -3.58 | 2025-02-26 | 10-K |
| Q3 2023 | 2022-09-30 | 0.26 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.57 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.03 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | -5.52 | 2024-02-28 | 10-K |
| Q3 2022 | 2021-09-30 | -4.98 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -4.17 | 2022-08-03 | 10-Q |
| Q1 2022 | 2021-03-31 | 2.09 | 2022-05-04 | 10-Q |
| FY 2022 | 2020-12-31 | 4.22 | 2023-03-01 | 10-K |
| Q3 2021 | 2020-09-30 | 1.87 | 2021-11-09 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.77 | 2021-08-03 | 10-Q |
| Q1 2021 | 2020-03-31 | -2.82 | 2021-05-04 | 10-Q |
| FY 2021 | 2019-12-31 | 9.09 | 2022-03-01 | 10-K |
| FY 2020 | 2019-09-30 | 1.78 | 2021-02-23 | 10-K |
| FY 2020 | 2019-06-30 | 4.56 | 2021-02-23 | 10-K |
| FY 2020 | 2019-03-31 | 1.47 | 2021-02-23 | 10-K |
| FY 2020 | 2018-12-31 | 7.30 | 2021-02-23 | 10-K |
| FY 2019 | 2018-09-30 | 2.41 | 2020-02-25 | 10-K |
| FY 2019 | 2018-06-30 | 1.50 | 2020-02-25 | 10-K |
| FY 2019 | 2018-03-31 | 0.75 | 2020-02-25 | 10-K |
| FY 2019 | 2017-12-31 | 7.96 | 2020-02-25 | 10-K |
| FY 2018 | 2017-09-30 | 1.03 | 2019-02-26 | 10-K |
| FY 2018 | 2017-06-30 | 1.72 | 2019-02-26 | 10-K |
| FY 2018 | 2017-03-31 | 1.41 | 2019-02-26 | 10-K |
| FY 2018 | 2016-12-31 | 6.41 | 2019-02-26 | 10-K |
| FY 2017 | 2016-09-30 | 1.45 | 2018-02-27 | 10-K |
| FY 2017 | 2016-06-30 | 1.85 | 2018-02-27 | 10-K |
| FY 2017 | 2016-03-31 | 1.21 | 2018-02-27 | 10-K |
| FY 2017 | 2015-12-31 | 5.23 | 2018-02-27 | 10-K |
| FY 2016 | 2015-09-30 | 1.39 | 2017-02-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.